{"id":156,"date":"2019-10-17T17:02:07","date_gmt":"2019-10-17T17:02:07","guid":{"rendered":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/4-4-ans-medication-classes\/"},"modified":"2025-01-16T22:25:49","modified_gmt":"2025-01-16T22:25:49","slug":"4-4-ans-medication-classes","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/4-4-ans-medication-classes\/","title":{"raw":"4.4 ANS Medication Classes","rendered":"4.4 ANS Medication Classes"},"content":{"raw":"Classes of medication, categorized according to neuroreceptor, are further discussed in more detail in the following sections. Table 4.4<sup>[footnote]This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">DailyMed<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Domain.<\/a>[\/footnote]<\/sup> contrasts agonist and antagonist medications for each ANS neuroreceptor.\n\nTable 4.4 Comparison of Prototype Medications That Stimulate Versus Inhibit PNS and SNS Receptors\n<table class=\"grid\">\n<tbody>\n<tr>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Receptor<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Stimulation (Agonist)<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Inhibition (Antagonist)<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Nicotine<\/strong><\/th>\n<td>Nicotine is a muscle relaxant with CNS effects. A <a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=5aadb95f-428c-b637-01f4-50d5866ced0c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>nicotine patch<\/strong><\/a> is used for nicotine addiction by slowly reducing dose and avoiding withdrawal effects<\/td>\n<td>Not clinically applicable<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Muscarinic<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=fa03947c-6844-45df-aa22-b584c5681269&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Pilocarpine<\/strong><\/a> causes muscle contraction; assists with glaucoma by contracting ciliary muscle and draining fluid<\/td>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=4c15d3cc-7888-4c82-b3f8-a5d93c5523df\" target=\"_blank\" rel=\"noopener\"><strong>Atropine<\/strong><\/a> in small doses inhibits secretions; in moderate doses increases heart rate; in large doses decreases gastrointestinal motility<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Alpha-1<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=1056d9da-8a3f-4b7a-878e-7f8d45d298cd&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Pseudoephedrine<\/strong><\/a> and <a class=\"rId48\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c40df8f6-8374-4f9b-bfce-94d582470d48&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Phenylephrine<\/strong><\/a> cause vasoconstriction, decreased swelling of mucus membranes, and decreased secretions<\/td>\n<td style=\"height: 169px; width: 311.644px;\"><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ed9988bc-0759-4c36-bee1-11b68dc1c84c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Tamsulosin<\/strong><\/a> relaxes smooth muscle in bladder\/prostate to improve urine flow and also decreases blood pressure due to vasodilation<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Alpha-2<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=accb2879-7c0e-40d9-bc78-af78fc619609&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Clonidine<\/strong><\/a> decreases CNS outflow to treat ADHD and also reduces blood pressure and heart rate<\/td>\n<td>Limited clinical use<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Beta-1<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=6b17b98b-e06d-42ed-925f-69aa2699dead&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Dobutamine<\/strong><\/a> increases heart rate, force of heart contraction, and speed of conduction between SA to AV nodes<\/td>\n<td style=\"height: 145px; width: 311.644px;\"><strong>Selective B blocker:<\/strong>\u00a0<a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=2d948600-35d8-4490-983b-918bdce488c8&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Metoprolol<\/strong><\/a> works on Beta-1 receptors to decrease blood pressure and heart rate<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Beta-2<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f8a2c4b7-a162-48ab-90b0-350e4da25c66\" target=\"_blank\" rel=\"noopener\"><strong>Albuterol<\/strong><\/a> used for bronchodilation<\/td>\n<td><strong>Nonselective B blocker:<\/strong> <a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=179e31a7-9956-4fba-9e9a-2ca28d37d42b&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Propranolol<\/strong><\/a> works on Beta-2 and Beta-1 receptors; decreases blood pressure but can also cause bronchoconstriction<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Catecholamines stimulate multiple adrenergic receptors<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=353f2d30-4b74-43eb-a2ff-26d593d283f8\" target=\"_blank\" rel=\"noopener\"><strong>Epinephrine<\/strong><\/a> and <a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a27fb6e0-8f7a-11db-9739-0050c2490048&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Norepinephrine<\/strong><\/a>\u00a0stimulate alpha-<span style=\"font-family: inherit; font-size: inherit;\"> and<\/span> beta-<span style=\"font-family: inherit; font-size: inherit;\">receptors on target organs, causing increased heart rate and vasoconstriction for improved blood flow to essential organs<\/span>\n\n<a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=cb97d4a0-89ed-407c-a763-209386b6f75c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Dopamine<\/strong><\/a> has dose-dependent effects that target arteries in the kidneys, heart, and brain<\/td>\n<td>Not clinically applicable<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nSee the supplementary YouTube videos in the boxes below related to sympathetic and parasympathetic nervous system medications.\n<div class=\"textbox\">\n<h3 class=\"video\">Sympathetic Nervous System Drugs<sup>[footnote]Forciea, B. (2018, January 12). <em>Sympathetic nervous system drugs<\/em> [Video]. YouTube. All rights reserved. Video used with permission.\u00a0<a href=\"https:\/\/youtu.be\/-e_s-jTPtm4\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/youtu.be\/-e_s-jTPtm4<\/a> [\/footnote]<\/sup><\/h3>\n[embed]https:\/\/www.youtube.com\/embed\/-e_s-jTPtm4[\/embed]\n\n&nbsp;\n<h3 class=\"video\">Parasympathetic Nervous System Drugs<sup>[footnote]Forciea, B. (2018, February 2).<em> Parasympathetic nervous system drugs<\/em> [Video]. YouTube. All rights reserved. Video used with permission. <a href=\"https:\/\/youtu.be\/ZSRk_NkbBPg\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/youtu.be\/ZSRk_NkbBPg<\/a>[\/footnote]<\/sup><\/h3>\n[embed]https:\/\/www.youtube.com\/embed\/ZSRk_NkbBPg[\/embed]\n\n&nbsp;\n\n<\/div>","rendered":"<p>Classes of medication, categorized according to neuroreceptor, are further discussed in more detail in the following sections. Table 4.4<sup><a class=\"footnote\" title=\"This work is a derivative of DailyMed by U.S. National Library of Medicine in the Public Domain.\" id=\"return-footnote-156-1\" href=\"#footnote-156-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup> contrasts agonist and antagonist medications for each ANS neuroreceptor.<\/p>\n<p>Table 4.4 Comparison of Prototype Medications That Stimulate Versus Inhibit PNS and SNS Receptors<\/p>\n<table class=\"grid\">\n<tbody>\n<tr>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Receptor<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Stimulation (Agonist)<\/strong><\/h5>\n<\/th>\n<th class=\"shaded\" scope=\"col\">\n<h5><strong>Inhibition (Antagonist)<\/strong><\/h5>\n<\/th>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Nicotine<\/strong><\/th>\n<td>Nicotine is a muscle relaxant with CNS effects. A <a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=5aadb95f-428c-b637-01f4-50d5866ced0c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>nicotine patch<\/strong><\/a> is used for nicotine addiction by slowly reducing dose and avoiding withdrawal effects<\/td>\n<td>Not clinically applicable<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Muscarinic<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=fa03947c-6844-45df-aa22-b584c5681269&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Pilocarpine<\/strong><\/a> causes muscle contraction; assists with glaucoma by contracting ciliary muscle and draining fluid<\/td>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=4c15d3cc-7888-4c82-b3f8-a5d93c5523df\" target=\"_blank\" rel=\"noopener\"><strong>Atropine<\/strong><\/a> in small doses inhibits secretions; in moderate doses increases heart rate; in large doses decreases gastrointestinal motility<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Alpha-1<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=1056d9da-8a3f-4b7a-878e-7f8d45d298cd&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Pseudoephedrine<\/strong><\/a> and <a class=\"rId48\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c40df8f6-8374-4f9b-bfce-94d582470d48&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Phenylephrine<\/strong><\/a> cause vasoconstriction, decreased swelling of mucus membranes, and decreased secretions<\/td>\n<td style=\"height: 169px; width: 311.644px;\"><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ed9988bc-0759-4c36-bee1-11b68dc1c84c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Tamsulosin<\/strong><\/a> relaxes smooth muscle in bladder\/prostate to improve urine flow and also decreases blood pressure due to vasodilation<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Alpha-2<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=accb2879-7c0e-40d9-bc78-af78fc619609&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Clonidine<\/strong><\/a> decreases CNS outflow to treat ADHD and also reduces blood pressure and heart rate<\/td>\n<td>Limited clinical use<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Beta-1<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=6b17b98b-e06d-42ed-925f-69aa2699dead&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Dobutamine<\/strong><\/a> increases heart rate, force of heart contraction, and speed of conduction between SA to AV nodes<\/td>\n<td style=\"height: 145px; width: 311.644px;\"><strong>Selective B blocker:<\/strong>\u00a0<a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=2d948600-35d8-4490-983b-918bdce488c8&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Metoprolol<\/strong><\/a> works on Beta-1 receptors to decrease blood pressure and heart rate<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Beta-2<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f8a2c4b7-a162-48ab-90b0-350e4da25c66\" target=\"_blank\" rel=\"noopener\"><strong>Albuterol<\/strong><\/a> used for bronchodilation<\/td>\n<td><strong>Nonselective B blocker:<\/strong> <a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=179e31a7-9956-4fba-9e9a-2ca28d37d42b&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Propranolol<\/strong><\/a> works on Beta-2 and Beta-1 receptors; decreases blood pressure but can also cause bronchoconstriction<\/td>\n<\/tr>\n<tr>\n<th scope=\"row\"><strong>Catecholamines stimulate multiple adrenergic receptors<\/strong><\/th>\n<td><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=353f2d30-4b74-43eb-a2ff-26d593d283f8\" target=\"_blank\" rel=\"noopener\"><strong>Epinephrine<\/strong><\/a> and <a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a27fb6e0-8f7a-11db-9739-0050c2490048&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Norepinephrine<\/strong><\/a>\u00a0stimulate alpha-<span style=\"font-family: inherit; font-size: inherit;\"> and<\/span> beta-<span style=\"font-family: inherit; font-size: inherit;\">receptors on target organs, causing increased heart rate and vasoconstriction for improved blood flow to essential organs<\/span><\/p>\n<p><a class=\"arrow\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=cb97d4a0-89ed-407c-a763-209386b6f75c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Dopamine<\/strong><\/a> has dose-dependent effects that target arteries in the kidneys, heart, and brain<\/td>\n<td>Not clinically applicable<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>See the supplementary YouTube videos in the boxes below related to sympathetic and parasympathetic nervous system medications.<\/p>\n<div class=\"textbox\">\n<h3 class=\"video\">Sympathetic Nervous System Drugs<sup><a class=\"footnote\" title=\"Forciea, B. (2018, January 12). Sympathetic nervous system drugs [Video]. YouTube. All rights reserved. Video used with permission.\u00a0https:\/\/youtu.be\/-e_s-jTPtm4\" id=\"return-footnote-156-2\" href=\"#footnote-156-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup><\/h3>\n<p><iframe loading=\"lazy\" id=\"oembed-1\" title=\"Sympathetic Nervous System  Drugs\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/-e_s-jTPtm4?feature=oembed&#38;rel=0&#38;rel=0\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<h3 class=\"video\">Parasympathetic Nervous System Drugs<sup><a class=\"footnote\" title=\"Forciea, B. (2018, February 2). Parasympathetic nervous system drugs [Video]. YouTube. All rights reserved. Video used with permission. https:\/\/youtu.be\/ZSRk_NkbBPg\" id=\"return-footnote-156-3\" href=\"#footnote-156-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/sup><\/h3>\n<p><iframe loading=\"lazy\" id=\"oembed-2\" title=\"Parasympathetic Nervous System Drugs\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/ZSRk_NkbBPg?feature=oembed&#38;rel=0&#38;rel=0\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-156-1\">This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">DailyMed<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">Public Domain.<\/a> <a href=\"#return-footnote-156-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-156-2\">Forciea, B. (2018, January 12). <em>Sympathetic nervous system drugs<\/em> [Video]. YouTube. All rights reserved. Video used with permission.\u00a0<a href=\"https:\/\/youtu.be\/-e_s-jTPtm4\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/youtu.be\/-e_s-jTPtm4<\/a>  <a href=\"#return-footnote-156-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-156-3\">Forciea, B. (2018, February 2).<em> Parasympathetic nervous system drugs<\/em> [Video]. YouTube. All rights reserved. Video used with permission. <a href=\"https:\/\/youtu.be\/ZSRk_NkbBPg\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/youtu.be\/ZSRk_NkbBPg<\/a> <a href=\"#return-footnote-156-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":83,"menu_order":4,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[48],"contributor":[],"license":[],"class_list":["post-156","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":140,"_links":{"self":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/users\/83"}],"version-history":[{"count":1,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/156\/revisions"}],"predecessor-version":[{"id":157,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/156\/revisions\/157"}],"part":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/140"}],"metadata":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/156\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/media?parent=156"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=156"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/contributor?post=156"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/license?post=156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}